Pharmaceutical Industry News
Analysis of regulation, quality, innovation, market and trends in Europe and Latin America.
Update the means of requesting GMP Inspection and AIM from Italy
Companies request that paper measures be sent by registered mail to the GMP Inspections and Authorizations Office....
AEMPS publishes resolution on Allergenic Medicines
AEMPS sets specific deadlines and publishes a list of allergenic medicines for authorization and marketing....
EU publishes ‘Consensus Statement’ on Medical Devices
The consensus statement on the EU medical devices regulation receives approval from the National Competent Authorities, including INFARMED....
Infarmed approves two new ACMs for cannabis formulas
Infarmed approves Satalliv and Tilray and increases the number of medicinal cannabis preparations available in Portugal to six....
First nasal medication to treat anaphylactic reactions
The EMA approves Eurneffy, the first nasal medicine for anaphylactic emergencies, through the Committee for Medicinal Products for Human Use....
EMA proposes approval of 10 new drugs
The EMA recommends the approval of 10 new drugs, highlighting Balversa and Eurneffy for emerging therapeutic innovations....
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.